Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin ), hydrocodone (Vicodin ), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Market Analysis and Insights: Global Opioids Market
The global Opioids market size is projected to reach US$ 18190 million by 2027, from US$ 15590 million in 2020, at a CAGR of 2.6% during 2021-2027.
Global Opioids Scope and Segment
The global Opioids market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
By the end users/application, this report covers the following segments
Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction
Others
Competitive Landscape:
The report provides a list of all the key players in the Opioids market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Opioids key manufacturers in this market include:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Market Analysis and Insights: Global Opioids Market
The global Opioids market size is projected to reach US$ 18190 million by 2027, from US$ 15590 million in 2020, at a CAGR of 2.6% during 2021-2027.
Global Opioids Scope and Segment
The global Opioids market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
By the end users/application, this report covers the following segments
Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction
Others
Competitive Landscape:
The report provides a list of all the key players in the Opioids market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Opioids key manufacturers in this market include:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
1 Opioids Market Overview
1.1 Opioids Product Overview
1.2 Opioids Market Segment by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Other
1.3 Global Opioids Market Size by Type
1.3.1 Global Opioids Market Size Overview by Type (2016-2027)
1.3.2 Global Opioids Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Opioids Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Opioids Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Opioids Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Opioids Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Opioids Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Opioids Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Opioids Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioids Sales Breakdown by Type (2016-2021)
1.4.2 Europe Opioids Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Opioids Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Opioids Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Opioids Sales Breakdown by Type (2016-2021)
2 Global Opioids Market Competition by Company
2.1 Global Top Players by Opioids Sales (2016-2021)
2.2 Global Top Players by Opioids Revenue (2016-2021)
2.3 Global Top Players Opioids Price (2016-2021)
2.4 Global Top Manufacturers Opioids Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioids Market Competitive Situation and Trends
2.5.1 Opioids Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioids Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids as of 2020)
2.7 Date of Key Manufacturers Enter into Opioids Market
2.8 Key Manufacturers Opioids Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioids Status and Outlook by Region
3.1 Global Opioids Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Opioids Historic Market Size by Region
3.2.1 Global Opioids Sales in Volume by Region (2016-2021)
3.2.2 Global Opioids Sales in Value by Region (2016-2021)
3.2.3 Global Opioids Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Opioids Forecasted Market Size by Region
3.3.1 Global Opioids Sales in Volume by Region (2022-2027)
3.3.2 Global Opioids Sales in Value by Region (2022-2027)
3.3.3 Global Opioids Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Opioids by Application
4.1 Opioids Market Segment by Application
4.1.1 Pain Relief
4.1.2 Anesthesia
4.1.3 Cough Suppression
4.1.4 Diarrhea Suppression
4.1.5 Deaddiction
4.1.6 Others
4.2 Global Opioids Market Size by Application
4.2.1 Global Opioids Market Size Overview by Application (2016-2027)
4.2.2 Global Opioids Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Opioids Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Opioids Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Opioids Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Opioids Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Opioids Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Opioids Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Opioids Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioids Sales Breakdown by Application (2016-2021)
4.3.2 Europe Opioids Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Opioids Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Opioids Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Opioids Sales Breakdown by Application (2016-2021)
5 North America Opioids by Country
5.1 North America Opioids Historic Market Size by Country
5.1.1 North America Opioids Sales in Volume by Country (2016-2021)
5.1.2 North America Opioids Sales in Value by Country (2016-2021)
5.2 North America Opioids Forecasted Market Size by Country
5.2.1 North America Opioids Sales in Volume by Country (2022-2027)
5.2.2 North America Opioids Sales in Value by Country (2022-2027)
6 Europe Opioids by Country
6.1 Europe Opioids Historic Market Size by Country
6.1.1 Europe Opioids Sales in Volume by Country (2016-2021)
6.1.2 Europe Opioids Sales in Value by Country (2016-2021)
6.2 Europe Opioids Forecasted Market Size by Country
6.2.1 Europe Opioids Sales in Volume by Country (2022-2027)
6.2.2 Europe Opioids Sales in Value by Country (2022-2027)
7 Asia-Pacific Opioids by Region
7.1 Asia-Pacific Opioids Historic Market Size by Region
7.1.1 Asia-Pacific Opioids Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Opioids Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Opioids Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioids Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Opioids Sales in Value by Region (2022-2027)
8 Latin America Opioids by Country
8.1 Latin America Opioids Historic Market Size by Country
8.1.1 Latin America Opioids Sales in Volume by Country (2016-2021)
8.1.2 Latin America Opioids Sales in Value by Country (2016-2021)
8.2 Latin America Opioids Forecasted Market Size by Country
8.2.1 Latin America Opioids Sales in Volume by Country (2022-2027)
8.2.2 Latin America Opioids Sales in Value by Country (2022-2027)
9 Middle East and Africa Opioids by Country
9.1 Middle East and Africa Opioids Historic Market Size by Country
9.1.1 Middle East and Africa Opioids Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Opioids Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Opioids Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioids Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Opioids Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Opioids Business
10.1 Teva
10.1.1 Teva Corporation Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Opioids Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Teva Opioids Products Offered
10.1.5 Teva Recent Development
10.2 Purdue Pharma
10.2.1 Purdue Pharma Corporation Information
10.2.2 Purdue Pharma Introduction and Business Overview
10.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Teva Opioids Products Offered
10.2.5 Purdue Pharma Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Corporation Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Mallinckrodt Opioids Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Amneal Pharma
10.4.1 Amneal Pharma Corporation Information
10.4.2 Amneal Pharma Introduction and Business Overview
10.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Amneal Pharma Opioids Products Offered
10.4.5 Amneal Pharma Recent Development
10.5 Collegium
10.5.1 Collegium Corporation Information
10.5.2 Collegium Introduction and Business Overview
10.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Collegium Opioids Products Offered
10.5.5 Collegium Recent Development
10.6 J&J
10.6.1 J&J Corporation Information
10.6.2 J&J Introduction and Business Overview
10.6.3 J&J Opioids Sales, Revenue and Gross Margin (2016-2021)
10.6.4 J&J Opioids Products Offered
10.6.5 J&J Recent Development
10.7 Endo
10.7.1 Endo Corporation Information
10.7.2 Endo Introduction and Business Overview
10.7.3 Endo Opioids Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Endo Opioids Products Offered
10.7.5 Endo Recent Development
10.8 Pfizer
10.8.1 Pfizer Corporation Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Pfizer Opioids Products Offered
10.8.5 Pfizer Recent Development
10.9 INSYS
10.9.1 INSYS Corporation Information
10.9.2 INSYS Introduction and Business Overview
10.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2016-2021)
10.9.4 INSYS Opioids Products Offered
10.9.5 INSYS Recent Development
10.10 Mylan
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Opioids Product Category, Application and Specification
10.10.3 Mylan Opioids Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Mylan Recent Development
10.11 Hikma
10.11.1 Hikma Corporation Information
10.11.2 Hikma Introduction and Business Overview
10.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Hikma Opioids Products Offered
10.11.5 Hikma Recent Development
10.12 Egalet
10.12.1 Egalet Corporation Information
10.12.2 Egalet Introduction and Business Overview
10.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Egalet Opioids Products Offered
10.12.5 Egalet Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioids Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioids Industrial Chain Analysis
11.4 Opioids Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioids Distributors
12.3 Opioids Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Opioids Product Overview
1.2 Opioids Market Segment by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Other
1.3 Global Opioids Market Size by Type
1.3.1 Global Opioids Market Size Overview by Type (2016-2027)
1.3.2 Global Opioids Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Opioids Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Opioids Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Opioids Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Opioids Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Opioids Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Opioids Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Opioids Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioids Sales Breakdown by Type (2016-2021)
1.4.2 Europe Opioids Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Opioids Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Opioids Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Opioids Sales Breakdown by Type (2016-2021)
2 Global Opioids Market Competition by Company
2.1 Global Top Players by Opioids Sales (2016-2021)
2.2 Global Top Players by Opioids Revenue (2016-2021)
2.3 Global Top Players Opioids Price (2016-2021)
2.4 Global Top Manufacturers Opioids Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioids Market Competitive Situation and Trends
2.5.1 Opioids Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioids Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids as of 2020)
2.7 Date of Key Manufacturers Enter into Opioids Market
2.8 Key Manufacturers Opioids Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioids Status and Outlook by Region
3.1 Global Opioids Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Opioids Historic Market Size by Region
3.2.1 Global Opioids Sales in Volume by Region (2016-2021)
3.2.2 Global Opioids Sales in Value by Region (2016-2021)
3.2.3 Global Opioids Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Opioids Forecasted Market Size by Region
3.3.1 Global Opioids Sales in Volume by Region (2022-2027)
3.3.2 Global Opioids Sales in Value by Region (2022-2027)
3.3.3 Global Opioids Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Opioids by Application
4.1 Opioids Market Segment by Application
4.1.1 Pain Relief
4.1.2 Anesthesia
4.1.3 Cough Suppression
4.1.4 Diarrhea Suppression
4.1.5 Deaddiction
4.1.6 Others
4.2 Global Opioids Market Size by Application
4.2.1 Global Opioids Market Size Overview by Application (2016-2027)
4.2.2 Global Opioids Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Opioids Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Opioids Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Opioids Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Opioids Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Opioids Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Opioids Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Opioids Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioids Sales Breakdown by Application (2016-2021)
4.3.2 Europe Opioids Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Opioids Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Opioids Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Opioids Sales Breakdown by Application (2016-2021)
5 North America Opioids by Country
5.1 North America Opioids Historic Market Size by Country
5.1.1 North America Opioids Sales in Volume by Country (2016-2021)
5.1.2 North America Opioids Sales in Value by Country (2016-2021)
5.2 North America Opioids Forecasted Market Size by Country
5.2.1 North America Opioids Sales in Volume by Country (2022-2027)
5.2.2 North America Opioids Sales in Value by Country (2022-2027)
6 Europe Opioids by Country
6.1 Europe Opioids Historic Market Size by Country
6.1.1 Europe Opioids Sales in Volume by Country (2016-2021)
6.1.2 Europe Opioids Sales in Value by Country (2016-2021)
6.2 Europe Opioids Forecasted Market Size by Country
6.2.1 Europe Opioids Sales in Volume by Country (2022-2027)
6.2.2 Europe Opioids Sales in Value by Country (2022-2027)
7 Asia-Pacific Opioids by Region
7.1 Asia-Pacific Opioids Historic Market Size by Region
7.1.1 Asia-Pacific Opioids Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Opioids Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Opioids Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioids Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Opioids Sales in Value by Region (2022-2027)
8 Latin America Opioids by Country
8.1 Latin America Opioids Historic Market Size by Country
8.1.1 Latin America Opioids Sales in Volume by Country (2016-2021)
8.1.2 Latin America Opioids Sales in Value by Country (2016-2021)
8.2 Latin America Opioids Forecasted Market Size by Country
8.2.1 Latin America Opioids Sales in Volume by Country (2022-2027)
8.2.2 Latin America Opioids Sales in Value by Country (2022-2027)
9 Middle East and Africa Opioids by Country
9.1 Middle East and Africa Opioids Historic Market Size by Country
9.1.1 Middle East and Africa Opioids Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Opioids Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Opioids Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioids Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Opioids Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Opioids Business
10.1 Teva
10.1.1 Teva Corporation Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Opioids Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Teva Opioids Products Offered
10.1.5 Teva Recent Development
10.2 Purdue Pharma
10.2.1 Purdue Pharma Corporation Information
10.2.2 Purdue Pharma Introduction and Business Overview
10.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Teva Opioids Products Offered
10.2.5 Purdue Pharma Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Corporation Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Mallinckrodt Opioids Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Amneal Pharma
10.4.1 Amneal Pharma Corporation Information
10.4.2 Amneal Pharma Introduction and Business Overview
10.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Amneal Pharma Opioids Products Offered
10.4.5 Amneal Pharma Recent Development
10.5 Collegium
10.5.1 Collegium Corporation Information
10.5.2 Collegium Introduction and Business Overview
10.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Collegium Opioids Products Offered
10.5.5 Collegium Recent Development
10.6 J&J
10.6.1 J&J Corporation Information
10.6.2 J&J Introduction and Business Overview
10.6.3 J&J Opioids Sales, Revenue and Gross Margin (2016-2021)
10.6.4 J&J Opioids Products Offered
10.6.5 J&J Recent Development
10.7 Endo
10.7.1 Endo Corporation Information
10.7.2 Endo Introduction and Business Overview
10.7.3 Endo Opioids Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Endo Opioids Products Offered
10.7.5 Endo Recent Development
10.8 Pfizer
10.8.1 Pfizer Corporation Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Pfizer Opioids Products Offered
10.8.5 Pfizer Recent Development
10.9 INSYS
10.9.1 INSYS Corporation Information
10.9.2 INSYS Introduction and Business Overview
10.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2016-2021)
10.9.4 INSYS Opioids Products Offered
10.9.5 INSYS Recent Development
10.10 Mylan
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Opioids Product Category, Application and Specification
10.10.3 Mylan Opioids Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Mylan Recent Development
10.11 Hikma
10.11.1 Hikma Corporation Information
10.11.2 Hikma Introduction and Business Overview
10.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Hikma Opioids Products Offered
10.11.5 Hikma Recent Development
10.12 Egalet
10.12.1 Egalet Corporation Information
10.12.2 Egalet Introduction and Business Overview
10.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Egalet Opioids Products Offered
10.12.5 Egalet Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioids Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioids Industrial Chain Analysis
11.4 Opioids Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioids Distributors
12.3 Opioids Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
